Inhibiting CK2α from Outside the Active Site

Poster   Mar 03, 2017

 
Inhibiting CK2α from Outside the Active Site
 
View Poster

Paul Brear[sup]1[/sup], Claudia De-Fusco[sup]2[/sup], Kathy Hadje Georgiou[sup]2[/sup], Nicola J. Francis-Newton[sup]3[/sup], Chris Stubbs[sup]2[/sup], Ashok R. Venkitaraman[sup]3[/sup], Chris Abell[sup]2[/sup], David Spring[sup]2[/sup], Marko Hyvonen[sup]1[/sup]

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 
 
 

OTHER POSTERS

Proteomics and Substrate Based MS Imaging of Xenobiotic Metabolising Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent Model

Poster

Untargeted proteomics analysis showed that human skin and a commercially available living skin equivalent model exhibit a similar distribution of xenobiotic metabolising enzymes. A new technique, substrate based mass spectrometry imaging (SB-MSI) was developed during this study.

READ MORE

Exploiting Polypharmacology in Precision Oncology: Identification of Differential Kinase Off-targets Among Clinical PARP Inhibitors

Poster

Can we use computational methods to identify previously unknown off-targets of PARP inhibitors that can explain their observed differences?

READ MORE

Bioluminescent Assay for GTPases Allows Measurement of GTPase, GAP and GEF Activities

Poster

We have developed a homogenous bioluminescent assay (GTPase-Glo) system to analyze these proteins in a simple, convenient “add-mix-read” format.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE